Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer
Di Wu1, Yang Zhang1, Luna Zhang1
1Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116027, People's Republic of China.
Objective:
The study investigated microRNA-152-3p-mediated autophagy and sensitivity of paclitaxel-resistant ovarian cancer cells.
Methods:
The miR-152-3p mimics and miR-152-3p inhibitor were transfected in A2780 cells and A2780T cells, and the scrambled sequences were transfected as a negative control group, the transfection efficiency was detected by qPCR technology. MTT was used to detect the proliferation and IC50 value of the cells after transfection. The expression of target proteins in A2780 cells and A2780T cells were detected by qPCR; The expression of phosphatase and tensin homolog (PTEN) and ATG4D after transfection were analyzed by Western blot. The knockdown efficiency of PTEN was detected by reverse qRT-PCR, MTT and Western blot.
Results:
The expression level of miR-152-3p in A2780T cells was 52-fold higher than that in A2780 cells according to the results of qPCR. Downregulation of miR-152-3p reversed PTX-induced autophagy, inhibited cell proliferation and apoptosis, and reduced drug resistance in A2780T cells. Moreover, PTEN appeared to be a potential target of miR-152-3p, and low expression levels of miR-152-3p increased PTX sensitivity by downregulating PTEN in vitro.
Conclusion:
PTEN may be a novel therapeutic target gene for patients with PTX-resistant ovarian cancer. These findings provide a potential translational framework for developing novel therapeutic strategies to overcome paclitaxel resistance in ovarian cancer.
Insights
microRNA-152-3p downregulation reverses paclitaxel resistance in ovarian cancer by inhibiting autophagy and downregulating PTEN. This suggests PTEN as a therapeutic target for paclitaxel-resistant ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ovarian cancer remains a leading cause of cancer-related mortality.
- Paclitaxel resistance is a major clinical challenge in ovarian cancer treatment.
- MicroRNAs play crucial roles in cancer progression and drug resistance.
Purpose of the Study:
- To investigate the role of microRNA-152-3p in paclitaxel-resistant ovarian cancer cells.
- To elucidate the underlying mechanisms, including autophagy and PTEN regulation.
- To explore the therapeutic potential of targeting miR-152-3p or its downstream effectors.
Main Methods:
- Transfection of miR-152-3p mimics and inhibitors in ovarian cancer cell lines (A2780 and A2780T).
- Quantitative PCR (qPCR) to assess miRNA and mRNA expression levels.
- MTT assays to evaluate cell proliferation and drug sensitivity (IC50).
- Western blotting to detect protein expression of PTEN and ATG4D.
Main Results:
- miR-152-3p expression was significantly higher in paclitaxel-resistant cells (A2780T) compared to sensitive cells (A2780).
- Downregulation of miR-152-3p reversed paclitaxel-induced autophagy, inhibited cell proliferation, promoted apoptosis, and reduced drug resistance.
- Phosphatase and tensin homolog (PTEN) was identified as a direct target of miR-152-3p, and its downregulation by miR-152-3p was crucial for sensitizing cells to paclitaxel.
Conclusions:
- miR-152-3p plays a critical role in modulating autophagy and paclitaxel sensitivity in ovarian cancer.
- PTEN is a key mediator of miR-152-3p's effects on paclitaxel resistance.
- PTEN represents a promising therapeutic target for overcoming paclitaxel resistance in ovarian cancer, offering a potential translational strategy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Stabilize Microtubules
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

